Schering-Plough

Schering Plough's drug rep in Catch-22?

PharmaGossip (Free subscription) | yesterday

Letter? What letter?

Russian nuclear corp. plans 4GW plant in Far East

Russia News Net (Free subscription) | 6 hours ago

VLADIVOSTOK, July 26 (RIA Novosti) - Russian state nuclear power corporation Rosatom plans to work with aluminum giant UC RusAl to build a 4GW nuclear plant and an aluminum factory in the Far East, a ...

Old Republic International Corp. Q2 2008 Earnings Call Transcript

Seeking Alpha (Free subscription) | 17 hours ago

Old Republic International Corporation (ORI) Q2 FY08 Earnings Call Complete Story »

ITT Corp. Q2 2008 Earnings Call Transcript

Seeking Alpha (Free subscription) | 19 hours ago

ITT Corporation (ITT) Q2 FY08 Earnings Call Complete Story »

MBF Financial: *Revised* Analyst Reports for Central Fund of Canada Limited, Global BPO Services Corporation, Marathon Acquisition Corp., and Contango Oil & Gas Company

Market Wire - Investment Opinion (Free subscription) | 07/24/2008

LONDON (MARKET WIRE) MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for Central Fund of Canada Limited (AMEX: CEF), Global BPO Services...

Vytorin: Dear Doctor Letter Readied

A Georgia Lawyer (Free subscription) | 07/24/2008

Vytorin is a drug made by a partnership of Merck & Schering-Plough. There's news that a letter has been readied to be sent to doctor who may be asking about recently released study results that showed patients taking the cholesterol drug were at higher risk of dying from cancer. Video (less than 90 seconds)here: http://www.cnbc.com/id/15840232?video=801729653 From various sites: The companies will...

LSI Corp. Q2 2008 Earnings Call Transcript

Seeking Alpha (Free subscription) | 07/24/2008

LSI Corporation (LSI) Q2 FY08 Earnings Call Complete Story »

After the Bell: Stocks Keep Modest Gains; Amazon Tops Estimates; Cramer: Housing Bill to Move Builders, Banks

World of stocks (Free subscription) | 07/23/2008

TheStreet.com After the Bell Cramer: Schering-Plough Unfairly Punished Stocks Lock In Modest Gains 7/23/2008 4:05 PM EDT Crude Oil Futures Fall Below $125 7/23/2008 4:01 PM EDT Amazon Tops Estimates (Update) 7/23/2008 5:04 PM EDT BioSante Seeks 'Female Viagra' Breakthrough BioSante's drug for the treatment of female sexual dysfunction, LibiGel, is entering Phase III trials. Find out what BioSante CEO...

Pactiv Corp. Q2 2008 Earnings Call Transcript

Seeking Alpha (Free subscription) | 07/23/2008

Pactiv Corporation (PTV) Q2 FY08 Earnings Call Complete Story »

Zacks Releases Four Powerful ''Buy'' Stocks: AK Steel Holding Corp., Chesapeake Energy, Aegean Marine Petroleum Network and SYNNEX Corporation

Business Wire (Free subscription) | 07/23/2008

CHICAGO--(BUSINESS WIRE)--Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one

Vytorin makers say cancer results likely an anomaly

Reuters UK (Free subscription) | 07/23/2008

WASHINGTON (Reuters) - Cancer findings in a new study of cholesterol drug Vytorin are "likely to be an anomaly" unrelated to the drug, makers Merck & Co and Schering-Plough Corp said in a letter to doctors.

Vytorin makers say cancer results likely an anomaly

Reuters (Free subscription) | 07/23/2008

WASHINGTON (Reuters) - Cancer findings in a new study of cholesterol drug Vytorin are "likely to be an anomaly" unrelated to the drug, makers Merck & Co and Schering-Plough Corp said in a letter to doctors.

Merck/Schering-Plough's Heart Drug Couldn't Have Done Worse

Seeking Alpha (Free subscription) | 07/23/2008

Derek Lowe submits: Merck (MRK) took the unusual step of delaying its earnings release Monday until after the close of the market. A report on another clinical study of Vytorin (ezetimibe), their drug with Schering-Plough (SGP), was coming out, so they put the numbers on hold until after the press release Monday afternoon. Naturally, this led to a lot of speculation about what was going on. A conspiracy-minded...

• Vytorin: Another Round of Nasty Results - In the Pipeline
• Stocks end mixed as oil rebounds - Star Tribune
• See the 20 articles on the same subject

ResponseLogix Gets $8 Million First Round For Online Automotive Leads; Both Belos Invest

Paidcontent (Free subscription) | 07/23/2008

ResponseLogix , a provider of lead response services for the online automotive industry, has raised an $8 million first round led by RP Partners and Shasta Ventures along with sister firms A. H. Belo ( NYSE: BLC ) Corporation and the Belo Corp. The SF-based startup, which launched last year, claims that online auto retailers have seen 50 percent increases in internet sales by using the service. The...

Vytorin Fails to Lower Heart Valve Problems

Medical,Health News and Articles (Free subscription) | 07/23/2008

July 21 — The controversial cholesterol drug Vytorin does not lower the risk of major heart valve problems, according to a report released Monday by its manufacturers, Schering-Plough Corp. and Merck & Co. In a multi-country study of 1,873 patients, the drug was no better than placebo at lowering the odds of major cardiovascular events [...]